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The aim of this study was to identify the mechanisms by which angiotensin II alters the
physiology of the pericyte-containing microvasculature of the retina. Despite evidence that
this vasoactive signal regulates capillary perfusion by inducing abluminal pericytes to contract
and thereby microvascular lumens to constrict, little is known about the events linking
angiotensin exposure with pericyte contraction. Here, using microvessels freshly isolated from
the adult rat retina, we monitored pericyte currents via perforated-patch pipettes, measured
pericyte calcium levels with fura-2 and visualized pericyte contractions and lumen constrictions
by time-lapse photography. We found that angiotensin activates nonspecific cation (NSC) and
calcium-activated chloride channels; the opening of these channels induces a depolarization
that is sufficient to activate the voltage-dependent calcium channels (VDCCs) expressed in the
retinal microvasculature. Associated with these changes in ion channel activity, intracellular
calcium levels rise, pericytes contract and microvascular lumens narrow. Our experiments
revealed that an influx of calcium through the NSC channels is an essential step linking the
activation of AT1 angiotensin receptors with pericyte contraction. Although not required in
order for angiotensin to induce pericytes to contract, calcium entry via VDCCs serves to
enhance the contractile response of these cells. In addition to activating nonspecific cation,
calcium-activated chloride and voltage-dependent calcium channels, angiotensin II also causes
the functional uncoupling of pericytes from their microvascular neighbours. This inhibition
of gap junction-mediated intercellular communication suggests a previously unappreciated
complexity in the spatiotemporal dynamics of the microvascular response to angiotensin II.
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The retina contains a rennin–angiotensin system (Kohler
et al. 1997) that may play a role in regulating blood flow
within this tissue. Consistent with this possibility, exposure
to angiotensin II causes retinal arterioles, capillaries and
venules to constrict, with smaller vessels being significantly
more sensitive than the larger vessels (Schonfelder et al.
1998; Kulkarni et al. 1999). Thus, angiotensin II is likely
to serve as a vasoactive signal regulating microvascular
perfusion in the retina.
Candidates for regulating blood flow at the capillary
level are the contractile pericytes, which are located on the
abluminal wall of microvessels. By contracting or relaxing,
these cells are thought to control capillary perfusion
(Tilton, 1991; Schonfelder et al. 1998; Kawamura et al.
2003). Suggestive of the particular importance of these
cells in the retinal microvasculature, the density of
pericytes is higher in the retina than in other tissues
(Shepro & Morel, 1993). However, at present, there is
only limited knowledge of the mechanisms by which
vasoactive molecules, such as angiotensin II, regulate
pericyte contractility and thereby lumen diameter and
local blood flow. Consequently, the goal of this study
was to identify events linking exposure of retinal
microvessels to angiotensin II with pericyte contraction
and vasoconstriction.
Based on the premise that ion channels are important
in mediating functional responses to vasoactive signals,
we assessed the effects of angiotensin II on the ionic
currents in pericyte-containing microvessels. We now
report that in microvessels freshly isolated from the rat
retina, this eight-amino acid peptide activates several types
of ion channels, including ones that provide pathways for
extracellular calcium to enter pericytes. Our studies further
revealed that an influx of calcium via nonspecific cation
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channels is a key event linking the activation of angiotensin
receptors with pericyte contraction and vasoconstriction.
In addition, we found that angiotensin II reversibly inhibits
cell-to-cell communication within retinal microvessels.
As a result, this peptide not only regulates the contractility
of individual pericytes, but also modifies the multicellular
functional organization of the retinal microvasculature.
Methods
Microvessel isolation
Animal use conformed to the guidelines of the Association
for Research in Vision and Ophthalmology and the
University of Michigan Committee on the Use and Care of
Animals. As detailed previously (Kawamura et al. 2003),
6- to 8-week Long-Evans rats (Harlan Sprague-Dawley,
Inc., Indianapolis, IN and Charles Rivers, Cambridge,
MA, USA) were killed with a rising concentration of
carbon dioxide, and their retinas were rapidly removed
and incubated in 2.5 ml Earle’s balanced salt solution,
which was supplemented with 0.5 mm EDTA, 20 mm
glucose, 15 u papain (Worthington Biochemicals,
Freehold, NJ, USA), and 2 mm cysteine for 30 min
at 30◦C and bubbled with 95% oxygen–5% carbon
dioxide in order to maintain pH and oxygenation.
After transfer to solution A (mm: 140 NaCl, 3 KCl,
1.8 CaCl2, 0.8 MgCl2, 10 Na-Hepes, 15 mannitol,
and 5 glucose at pH 7.4 with osmolarity adjusted to
310 mosmol 1−1), each retina was then gently sandwiched
between two glass coverslips (15 mm diameter, Warner
Instrument Corp., Hamden, CT, USA). As reported
previously (Sakagami et al. 1999a; Kawamura et al.
2003), vessels adhered to the coverslip that was in
contact with the vitreal side of the retina. By repeating
this tissue print step, several coverslips containing
microvessels could be obtained from a retina. Figure 1
shows a photomicrograph of a segment of a freshly
isolated pericyte-containing microvessel. Other photo-
graphs of retinal microvessels isolated by this method
are in Sakagami et al. (1999), Oku et al. (2001) and Wu
et al. (2001); in addition, a time-lapse video of an isolated
Figure 1. Differential interference contrast photomicrograph of
a portion of a pericyte-containing microvessel freshly isolated
from the rat retina
Arrowheads point to pericytes. Five red blood cells can be seen within
the lumen. Scale bar = 10 µm.
retinal microvessel is in the supplemental material. Our
experiments were performed on microvessels that were
>300 µm in length.
Time-lapse photography
As detailed elsewhere (Kawamura et al. 2003; Wu
et al. 2003), a glass coverslip containing isolated
pericyte-containing microvessels was positioned in a
perfusion chamber (volume = 200 µl) on the stage
of a Nikon Eclipse E800 equipped with differential
interference contrast optics. Microvessels were viewed
at ×1000 magnification with the aid of a ×100 oil
objective. After a 2.67 min control period, microvessels
were exposed for 5.33 min to an experimental solution
and then re-exposed to the control perfusate (solution A).
To facilitate detection of pericyte contractions, time-lapse
images were recorded at 8 s intervals using a Nikon
DCM1200 digital camera and ImagePro Plus software
(Version 4.5, Media Cybernetics, Silver Spring MD,
USA). The occasional pericytes (<5%) that spontaneously
contracted and relaxed were not included in our analyses.
As detailed previously (Wu et al. 2003), our calculation
of the probability that responding pericytes were located
near (≤30 µm) capillary branch points was based on our
observation that 20% of the length of the monitored
microvessels was within 30 µm of a bifurcation.
Measurement of lumen diameters at sites adjacent to
contracting pericytes was facilitated by use of ImagePro
Plus software. Because contracting pericytes could cause
microvascular lumens to move out of the narrow depth
of focus available with differential interference contrast
optics at high magnification, only those lumens that
remained in focus throughout an experiment were
included. During exposure to an experimental perfusate,
lumen diameters were measured when the change in
responsive vessels was maximal.
Calcium imaging
After freshly isolated microvessels were exposed to
solution A supplemented with 1 µm fura-2AM (Molecular
Probes, Eugene, OR, USA) at 37◦C for 30 min, the
extracellular fura-2AM was washed out with solution A
for at least 30 min. A coverslip containing microvessels
with fura-loaded cells was positioned in a perfusion
chamber (volume = 1 ml), which was perfused at
∼2 ml min−1. Digital imaging of fluorescence was
performed at room temperature using an intensified
CCD camera with a 12-bit dynamic range (Sensicam,
Cooke Corp., Auburn Hills, MI, USA); the light source
was a high-intensity mercury lamp coupled to a mono-
chromator (Cairn Research Ltd, Faverhsam, UK).
Imaging Workbench 5 (Indec BioSystems, Mountain
View, CA, USA) was used to control the imaging
equipment and collect data. Microvessels were viewed
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at ×40 using a Nikon Eclipse TE300 microscope
equipped with a ×40 oil-immersion objective. We
measured fluorescent intensities at 340 nm and
380 nm from pericyte somas, which were defined as
regions of interest (ROIs) using the imaging software.
Subsequently, the 340 : 380 fluorescence ratio was
calculated. Conversion to intracellular calcium
concentration was achieved by using the equation
of Grynkiewicz et al. (1985) in which Rmin and Rmax
were determined by measuring the fluorescence ratio in
fura-loaded pericytes located on freshly isolated micro-
vessels exposed to calcium calibration buffer solutions
(C-3009, Sigma) containing 0 µm and 39 µm free
calcium and supplemented with the calcium ionophore,
ionomycin (5 µm). Autofluorescence was not detected in
the isolated retinal microvessels.
The basal concentration of pericyte calcium was
defined as the mean concentration during the minute
prior to angiotensin exposure. The peak increase in
calcium level was defined as the mean of the three
peri-peak determinations. The effect of nifedipine was
assessed 1.5–3 min after the onset of exposure to the
angiotensin-containing perfusate. We compared the mean
calcium concentration during the 30 s period prior to
nifedipine exposure with the maximal amount detected
during exposure to this calcium channel blocker. In
some experiments, we used a calcium-free perfusate that
consisted of solution A without CaCl2 and with 3 mm
EGTA.
Electrophysiology
A coverslip containing microvessels was placed in a
recording chamber, which was initially perfused with
solution A. Vessels were examined at ×400 magnification
with an inverted microscope equipped with phase-
contrast optics. Pericytes could be identified by their
characteristic ‘bump on a log’ location on the abluminal
wall of microvessels that had outer diameters of less
than 7 µm (Kuwabara & Cogan, 1960; Sakagami et al.
1999). As detailed previously (Sakagami et al. 1999a),
the perforated-patch configuration of the patch-clamp
technique was used to monitor the ionic currents and
the membrane potentials of pericytes located on micro-
vessels that had been isolated from a retina within 3 h.
The pipette solution consisted of (mm) 50 KCl, 64
K2SO4, 6 MgCl2, 10 K-Hepes, 240 µg ml−1 amphotericin,
and 240 µg ml−1 nystatin at pH 7.4 with the osmolarity
adjusted to 280 mosmol l−1. The pipettes, which had
resistances of ∼5 M, were mounted in the holder
of a patch-clamp amplifier (Model 200B from Axon
Instruments, Inc., Union City, CA or Model 3900 A from
Dagan Corp., Minneapolis, MN, USA); seals of ≥10 G
were made to the cell bodies of pericytes. As
amphotericin/nystatin perforated the patch, the access
resistance to the pericytes studied decreased to less than
25 M within 5 min. As discussed previously (Sakagami
et al. 1999; Li & Puro, 2001; Oku et al. 2001; Wu
et al. 2001; Kawamura et al. 2002; Kawamura et al.
2003; Wu et al. 2003), it appears that the voltage could
be clamped reasonably well for the identification of
ionic conductances, despite the complex morphology of
pericytes and the presence of gap junctions with other
microvascular cells (Oku et al. 2001; Kawamura et al.
2002).
For continuous recordings of voltage, pericytes were
clamped at zero current, and the voltage was sampled
at 50 ms intervals. Adjustment for the calculated liquid
junction potential (Barry, 1994) was made after data
collection. In voltage-clamp experiments, the steady
state current–voltage (I–V ) relations were determined by
recording the currents evoked by voltage-steps, which were
controlled with pCLAMP 8 software (version 8.2, Axon
Instruments), and were filtered at 1 kHz with a four-pole
Bessel filter, digitally sampled at 1 ms intervals using a
DigiData 1200B acquisition system (Axon Instruments)
and stored by a computer equipped with pCLAMP and
Origin (Version 7, OriginLab, Northampton, MA, USA)
software for data analysis and graphics display. The mean
current during the last 25 ms of each step was plotted
versus the voltage of the step.
The amplitude of the nonspecific cation current was
measured from recordings sampled at 500 µs intervals
from pericytes voltage clamped at −103 mV, which is the
equilibrium potential for potassium. From these records,
we also calculated the amplitude of the transient inward
currents, which are generated by ClCa channels (Sakagami
et al. 1999); for each 1 s of sampling time, the transient
inward current was calculated by subtracting the
amplitude of the current that occurred in the absence
of transient events from the average current amplitude,
which was determined with pCLAMP software, as we have
detailed previously (Kawamura et al. 2003). The amplitude
of the peak ClCa current was defined as the mean of the
three peri-peak values.
In a series of experiments designed to determine
the ionic selectivity of one of the angiotensin-induced
conductances (summarized in Table 1 and Fig. 5), the
recording pipettes were filled with (mm) 135 CsCl, 6 MgCl2
and 10 Cs-Hepes at pH 7.4 and 280 mosmol l−1; micro-
vessels were exposed to solution B (mm: 30 CsCl, 1.8
CaCl2, 1.8 BaCl2, 0.8 MgCl2, 10 Cs-Hepes, 5 glucose and
207 mannitol at pH 7.4) or modifications of solution B in
which 43.6 mm choline chloride (the ‘high chloride’ group
in Table 1 and Fig. 5), 30 mm NaCl (‘high sodium’), 30 mm
KCl (‘high potassium’) or 20 mm CaCl2 (‘high calcium’)
were added, and the concentration of mannitol was
adjusted to maintain the osmolarity at 310 mosmol l−1.
For analysis of the membrane capacitive currents,
voltage-clamp recordings were filtered at 10 kHz and
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Table 1. Effect of changes in the ionic composition of the bathing solution on the
reversal potential (V rev) of the angiotensin-induced current
Extracellular [Cl−]o [Na+]o [K+]o [Ca2+]o Vrev
solution (mM) (mM) (mM) (mM) (mV)
Solution B 38.8 0 0 1.8 −28 ± 2
High chloride 82.4 0 0 1.8 −25 ± 4
High sodium 68.8 30 0 1.8 −7 ± 2∗
High potassium 68.8 0 30 1.8 −9 ± 2∗
High calcium 95.4 0 0 21.8 −8 ± 2∗
∗ P < 0.001. The composition of the extracellular solutions is detailed in the
Methods section.
digitally sampled at 25 µs intervals; curve-fitting software
(pCLAMP) was used to assess whether the decay
of a membrane capacitive current fitted a first-order
exponential function. Using pCLAMP software also
facilitated our calculation of the area under the decaying
capacitive current, i.e. the charge displacement, which was
used as one indicator of the effect of angiotensin II on this
current.
Chemicals
Unless otherwise noted, chemicals were obtained from
Sigma.
Statistics
Data are given as means ± s.e.m. Unless otherwise noted,




We used time-lapse photography to monitor the effect
of angiotensin II on pericyte-containing microvessels
freshly isolated from the adult rat retina. In each
of 36 monitored microvascular complexes, at least
one pericyte contracted during exposure to 500 nm
angiotensin II; induced relaxations were not observed.
Of the 193 monitored pericytes that were exposed
to 500 nm angiotensin II, reversible contractions were
observed in 34%. Responding pericytes were observed
at sites throughout the microvascular complexes; unlike
muscarinic agonists (Wu et al. 2003), angiotensin II did
not preferentially (P = 0.3, Fisher’s exact test) induce
contractions in pericytes positioned near vascular
bifurcations.
The number of pericytes induced to contract was
dependent upon the dose of angiotensin II (Fig. 2A),
with the half-maximally effective concentration being
∼15 nm. Consistent with the activation of AT1 receptors
mediating pericyte contraction, the selective agonist for
these receptors, L162313 (100 nm), effectively induced
contractions within pericyte-containing microvessels
(Fig. 2B). Associated with pericyte contraction, micro-
vascular lumens narrowed (see the time-lapse movie in
the supplemental material). During exposure to 500 nm
angiotensin II, lumens adjacent to contracting pericytes
narrowed by 54% (P < 0.001, Fig. 2C). From our
time-lapse experiments, we concluded that freshly
isolated microvessels provide a useful preparation in
which to test hypotheses concerning the mechanism by
which angiotensin II causes vasoconstriction in the retinal
microvasculature.
Angiotensin-induced calcium increase
Because intracellular calcium regulates the contrac-
tility of pericytes (Kawamura et al. 2003; Wu
et al. 2003), we hypothesized that this divalent
cation plays a role in the response of these cells to
angiotensin II. To begin to test this possibility, we
incubated freshly isolated microvessels for 10 min
in a bathing solution containing 10 µm BAPTA-AM
(1,2-bis(2-aminophenoxy)ethane-N ,N ,N ′,N ′-tetraacetic
acid tetra(acetoxymethyl) ester), which is a cell-permeable
calcium chelator. After this treatment, 500 nm
angiotensin II failed to induce pericyte contractions
(Fig. 2B); this was significantly (P < 0.001) different
than the response rate in the absence of BAPTA. Our
experiments using BAPTA support the idea that a change
in intracellular calcium is an important step linking
angiotensin exposure with pericyte contraction.
To help elucidate the mechanisms by which
angiotensin II regulates the intracellular concentration of
calcium, we monitored calcium levels in pericyte somas.
As illustrated in Fig. 3 (left-hand panel), angiotensin II
induced a transient increase in pericyte calcium when
the perfusate lacked this divalent cation. In a series
of experiments using a calcium-free perfusate (see
Methods), the peak calcium increase during exposure to
500 nm angiotensin II was 123 ± 12 nm in the 44 of 52
monitored pericytes that had a detectable response. This
increase was significantly (P < 0.001) above the basal
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Figure 2. Effect of angiotensin II on the contractility of pericytes located on freshly isolated retinal
microvessels
A, relationship between the concentration of angiotensin and the percentage of pericytes induced to contract.
At angiotensin concentrations of ≥10 nM, the percentage of contracting pericytes was significantly (P < 0.001,
Fisher’s exact test) increased. The number of pericytes monitored by time-lapse photography was 292, 24, 31, 21,
23 and 193 for angiotensin concentrations of 0, 5, 10, 25, 50 and 500 nM, respectively. B, the contractile effect of
angiotensin II and an AT1 receptor agonist under various conditions. The labelled columns indicate the groups in
which the perfusate (solution A) was supplemented with angiotensin II (500 nM), L162313 (100 nM), BAPTA-AM
(10 µM), nifedipine (10 µM) or chelerythrine (1 µM) or was modified by omitting CaCl2 and adding 3 mM EGTA.
Compared with the angiotensin group, ∗P ≤ 0.005 (Fisher’s exact test). The number of pericytes monitored by
time-lapse photography was 193, 73, 41, 23, 73 and 68 for the angiotensin, L162313, BAPTA, calcium-free,
nifedipine and chelerythrine groups, respectively. C, effect of 10 µM nifedipine and 1 µM chelerythrine on vaso-
constriction induced by 500 nM angiotensin II. Compared with the control value, ∗ P ≤ 0.005 (Student’s paired
t test). The vasoconstriction induced by angiotensin in the presence of nifedipine was significantly (P = 0.006) less
than the constriction induced in the absence of this calcium channel inhibitor. The presence of chelerythrine did
not significantly (P = 0.8) affect the magnitude of the angiotensin-induced vasoconstriction. Because exposure to
either nifedipine or chelerythrine did not significantly (P > 0.1) affect lumen diameter, the control value shown is
the mean diameter of microvessels exposed to solution A without (n = 12) or with nifedipine (n = 6) or chelerythrine
(n = 6). The number of monitored lumens was 24, 12, 6 and 6 for the control, angiotensin, angiotensin/nifedipine
and angiotensin/chelerythrine groups, respectively. Error bars show S.E.M.
level. Because intracellular calcium levels rose despite
the absence of calcium in the extracellular solution, we
concluded that angiotensin II evokes a release of calcium
from intracellular stores.
Figure 3. Angiotensin-induced changes in pericyte calcium
Plot of the mean intracellular calcium concentration versus time for 10 pericytes located on a freshly isolated
microvascular complex; two other pericytes on this microvessel lacked detectable changes in their calcium levels.
Left-hand panel, the perfusate was a modification of solution A in which CaCl2 was omitted and 3 mM EGTA
was added. Right-hand panel, the perfusate consisted of solution A, which contained 1.8 mM CaCl2. Periods
of exposure to 500 nM angiotensin II, 10 µM nifedipine, the calcium-free perfusate and the calcium-containing
perfusate (solution A) are shown by bars.
In contrast to the transient increase in pericyte
calcium induced when angiotensin II was in a calcium-free
perfusate, a plateau phase of increased calcium followed
the peak increase when pericytes were exposed to
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this peptide in a calcium-containing perfusate (Fig. 3,
right-hand panel). During the plateau phase, the calcium
concentration in the responding pericytes (50 of the 56
monitored cells) was 75 ± 3 nm greater than the basal
calcium level; this was a significant (P < 0.001) increase.
These experiments demonstrated that angiotensin II
induces an influx of calcium, as well as its release from
intracellular stores.
To determine whether the angiotensin-induced release
of stored calcium was sufficient to trigger pericyte
contraction, microvessels were monitored by time-lapse
photography during exposure to 500 nm angiotensin II
in a calcium-free perfusate. Under these conditions,
a detectable contraction was induced in only 4% of
the monitored pericytes (Fig. 2B). This was significantly
(P = 0.005, Fisher’s exact test) less that the 34% incidence
of contracting pericytes observed during exposure of
microvessels to 500 nm angiotensin II in the presence of
extracellular calcium. Because the angiotensin-induced
release of calcium rarely triggered pericyte contraction,
it seems likely that an influx of extracellular calcium is
a vital step linking angiotensin exposure with pericyte
contraction.
Angiotensin-induced ionic conductances
To further elucidate the mechanisms by which
angiotensin II affects the physiology of retinal capillaries,
Figure 4. Effect angiotensin II on the electrophysiology of pericyte-containing retinal microvessels
A, time course for the effect of 500 nM angiotensin II (bar) on the membrane potential of pericytes (n = 6) located
on freshly isolated microvessels. Voltage was sampled at 50 ms intervals; the black line shows the means and the
vertical grey lines the S.E.M.s. B, current traces before angiotensin II exposure (Control), 15–60 s after the onset of
exposure to 500 nM angiotensin II, and approximately 5 min after washout of angiotensin II. The clamp protocol is
shown below. C, I–V plots of the steady-state currents shown in B. Control (); Angiotensin II (•); Recovery ().
D, mean angiotensin-induced current (difference between angiotensin and control) recorded in nine pericytes. E,
time course for the effect of 500 nM angiotensin II (bar) on the current recorded in pericytes (n = 7) clamped at
−58 mV and sampled at 50 ms intervals. To facilitate determination of the mean angiotensin-induced current,
the current record was adjusted for each to the seven sampled pericytes so that at 2 min prior to exposure to
angiotensin II, the current amplitude was 0 pA. The black line shows the means and the vertical grey lines the
S.E.M.s of the adjusted current records.
we obtained patch-clamp recordings from pericytes
located on freshly isolated microvessels. In the
current-clamp recordings, the membrane potential
of six of seven sampled pericytes decreased during
exposure of microvessels to 500 nm angiotensin II.
Specifically, the responding cells depolarized from
−41 ± 2 mV to −26 ± 5 mV (P < 0.014). Subsequently,
the membrane potential increased, but remained less
than the resting level throughout a 5 min exposure to this
peptide. The time course for the effect of angiotensin
on the voltage of the responding pericytes is shown in
Fig. 4A. With cessation of angiotensin exposure,
repolarization occurred.
To establish the ionic basis for the angiotensin-induced
depolarization, we recorded from voltage-clamped
pericytes. As illustrated in Fig. 4B and C, comparison
of the current–voltage relations before and 15–60 s
after the onset of exposure of microvessels to 500 nm
angiotensin II demonstrated that this peptide activated
a depolarizing conductance, which was reversible. In a
series of similar experiments (n = 9), we detected
a depolarizing conductance in 89% of the sampled
pericytes; the reversal potential of the angiotensin-induced
current, i.e. the difference current between angiotensin
and control, was −10 ± 2 mV (Fig. 4D). This induced
inward current measured at −103 mV increased to a
peak amplitude of 100 ± 8 pA at 18 ± 3 s (n = 7) after
the onset of angiotensin exposure. In other voltage-clamp
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experiments, we systematically varied the composition
of the bathing solution in order to determine the ionic
selectivity of this angiotensin-induced conductance. We
observed that the reversal potential of this induced current
was significantly (P < 0.001) affected by changes in the
extracellular concentration of sodium, potassium and
calcium, but was not significantly (P = 0.54) affected
by changes in chloride (Fig. 5 and Table 1). From
these findings, we concluded that that this depolarizing
conductance is generated by the activation of nonspecific
cation (NSC) channels whose permeability ratio, based
on the extended constant-field voltage equation with
assumptions similar to those of Mayer and Westbrook
(Mayer & Westbrook, 1987), is PCa/PNa,K = 3. Thus,
the angiotensin-activated NSC channels not only cause
pericytes to depolarize, but also provide pathways for the
entry of calcium ions.
In addition to activating an NSC conductance,
angiotensin II also activated transiently occurring inward
currents (Fig. 6A), which we previously demonstrated are
generated by calcium-activated chloride (ClCa) channels
(Sakagami et al. 1999). For the seven of eight sampled
pericytes that had conductances activated by 500 nm
angiotensin II, the transient inward currents measured
at −103 mV increased significantly (P < 0.001), from a
basal level of 9.4 ± 4.3 pA to a peak of 42 ± 6 pA. The
time course for the activation of the ClCa conductance
is shown in Fig. 6B. Consistent with these channels
being activated by calcium, incubation of micro-
vessels for 10 min in 10 µm BAPTA-AM prevented
500 nm angiotensin II from significantly (P = 0.5, n = 6)
increasing the ClCa conductance. In contrast, treatment
with BAPTA-AM did not prevent angiotensin II from
activating an NSC conductance whose peak amplitude was
not significantly (P = 0.3, n = 6) different than when it
was induced in the absence of BAPTA. Taken together,
our electrophysiological experiments demonstrated that
angiotensin II activates NSC and ClCa channels; both of
which cause pericytes to depolarize.
Role of calcium influx via voltage-dependent
calcium channels
Because the angiotensin-induced depolarization is
sufficient to activate the voltage-dependent calcium
channels (VDCCs) expressed in the retinal micro-
vasculature (Sakagami et al. 1999), we considered the
possibility that these channels are important calcium
influx pathways. To begin to assess the role of
VDCCs in mediating the response to angiotensin II,
we exposed microvessels to nifedipine, which we
previously demonstrated blocks the L-type VDCC
expressed by retinal pericytes (Sakagami et al. 1999,
2001). As illustrated in Fig. 3 (right-hand panel), the
plateau phase of the angiotensin-induced increase in
pericyte calcium was partially dimininshed when the
perfusate was supplemented with 10 µm nifedipine. On
average, nifedipine diminished this angiotensin-induced
increase by 35 ± 4% (P < 0.001, paired student’s t test;
n = 12 microvessels with 5 ± 2 pericytes monitored per
complex).
Because opened VDCCs, as well as the
angiotensin-activated NSC channels, would provide
pathways for calcium influx, the question arose as to the
role of these calcium channels in mediating the contractile
response of pericytes during angiotensin exposure.
Figure 5. Effect of extracellular ions on the current–voltage
relations of the angiotensin-induced current
The composition of the extracellular solutions is detailed in the
Methods section. Data points show the mean with the S.E.M. of the
steady-state currents induced by 500 nM angiotensin II. The number of
sampled pericytes was 4, 3, 4, 7 and 5 for the solution B, high
chloride, high sodium, high potassium and high calcium groups,
respectively. Error bars show S.E.M.
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Using time-lapse photography, we observed that 10 µm
nifedipine did not significantly (P = 1.0, Fisher’s exact
test) affect the percentage of pericytes that were induced
to contract during exposure 500 nm angiotensin II
(Fig. 2B). On the other hand, this VDCC blocker did
diminish the magnitude of the angiotensin-induced
vasoconstriction (Fig. 2C). Specifically, in the presence
of 10 µm nifedipine, 500 nm angiotensin II caused
microvascular lumens at sites adjacent to contracting
pericytes to narrow by 22 ± 3% (n = 6). Although this
was a significant (P = 0.001) vasoconstriction, it was
significantly (P = 0.006) less than the 54 ± 8% decrease
in lumen diameter induced by 500 nm angiotensin II
in the absence of this VDCC blocker. Thus, although
VDCCs are not essential for the triggering of angiotensin-
induced contractions, their activation enhances the
contractile response and thereby the magnitude of the
vasoconstriction.
Inhibition of cell-to-cell coupling
In addition to demonstrating that angiotensin II activates
depolarizing NSC and ClCa currents, our electro-
physiological recordings also revealed that this peptide
affects the membrane capacitive current. This is illustrated
in Fig. 7A and also the current traces in Fig. 4B. This
capacitive current is of interest because, as predicted
from a modelling analysis (Lindau & Neher, 1988) and
confirmed in our studies of pericytes located on retinal
microvessels (Oku et al. 2001; Kawamura et al. 2003), the
time course for the decay of the membrane capacitive
current is fitted by a first-order exponential function
when a cell is uncoupled, but is complex when a cell is
electrotonically coupled to its neighbours. As reported
previously (Oku et al. 2001; Kawamura et al. 2002;
Kawamura et al. 2003), we observed that under control
conditions, the membrane capacitive current recorded in
pericytes has a complex rate of decay (Fig. 7A, left-hand
Figure 6. Effect of angiotensin II on
calcium-activated chloride currents
A, in each panel, 15 current traces of a
pericyte held at −103 mV are
superimposed to show transient inward
currents before (Control) and 15–60 s after
the onset of exposure to 500 nM
angiotensin II. B, mean ClCa current
calculated at 5 s intervals before and
during exposure to 500 nM angiotensin II
(bar).
panel). However, approximately 20–60 s after the onset
of exposure to 500 nm angiotensin II, the decay rate of
the membrane capacitive current decreased in 16 of
21 monitored pericytes; subsequently the decay rate
could be fitted by a first-order exponential function
(Fig. 7A, right-hand panel). In agreement with hundreds
of perforated-patch recordings done in our previous
studies of pericyte-containing retinal microvessels, we did
not observe in this study spontaneous changes in the
capacitance transient during control periods (n = 53).
The effect of angiotensin II on the membrane capacitive
current was transient, as illustrated in Fig. 7B. After
approximately 3 min of continued exposure to 500 nm
angiotensin II, the decay rate of the membrane capacitive
current again became complex. From this series of
experiments, we concluded that angiotensin exposure
results in the transient closure of the intercellular pathways
that are known to electronically couple pericytes with their
microvascular neighbours (Kawamura et al. 2003).
From earlier studies, we concluded that protein
kinase C (PKC) regulates the gap junction pathways of
retinal microvessels (Oku et al. 2001; Kawamura et al.
2002). For example, exposure to the PKC activator
phorbol myristate markedly reduces gap
junction-mediated intercellular communication (Oku
et al. 2001). Based on the PKC-sensitivity of micro-
vascular gap junctions, we considered the hypothesis
that this enzyme plays a role in the angiotensin-induced
uncoupling of pericytes. To test this idea, we exposed
freshly isolated microvessels to chelerythrine (1 µm),
which is a potent inhibitor of most PKC isoforms (Herbert
et al. 1990), and prevented 500 nm angiotensin II from
having a detectable effect on the membrane capacitive
current recorded in each of seven sampled pericytes. This
lack of effect in the presence of chelerythrine contrasted
significantly (P = 0.001, Fisher’s exact test) with our
observation that in the absence of this PKC inhibitor,
exposure to 500 nm angiotensin II switched the decay
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rate of the membrane capacitive current in 76% of the
sampled pericytes (n = 21) from being complex to being
fitted by a first-order exponential function.
In another series of experiments, we tested the
hypothesis that the angiotensin-induced rise in calcium,
which can activate a number of PKC isoforms, plays
a role in the closure of the gap junctions that
couple pericytes with their microvascular neighbours.
Consistent with possibility, incubation of isolated
microvessels for 36 ± 6 min in solution A supplemented
with 10 µm BAPTA-AM prevented 500 nm angiotensin II
from affecting the membrane capacitive current in each
of four sampled pericytes. This contrasted significantly
(P = 0.004, Fisher’s exact test) with our observation
that in the absence of this calcium chelator, 16 of 19
pericytes showed a change in the decay rate of the
membrane capacitive current during exposure to 500 nm
angiotensin II. Taken together, our experiments indicate
that the rise in intracellular calcium and the activation
of PKC are important steps leading to the inhibition of
intercellular electrotonic transmission during exposure of
retinal microvessels to angiotensin II.
Effect of chelerythrine on induced conductances
and vasoconstriction
Having found that PKC is likely to play a role in
the angiotensin-induced uncoupling of pericytes,
we asked whether this enzyme was also critical
for the angiotensin-induced activation of NSC and
ClCa conductances. However, inconsistent with this
possibility, we found that chelerythrine did not prevent
angiotensin from activating these currents in pericytes
(Fig. 8A). Further, the peak amplitudes of the
angiotensin-induced NSC and ClCa currents were
not significantly (P > 0.07) affected by this PKC
inhibitor (Fig. 8B). Specifically, in the presence of
1 µm chelerythrine, 500 nm angiotensin II induced
peak NSC and ClCa currents (measured at −103 mV)
of 118 ± 26 pA and 50 ± 6 pA (n = 7), respectively;
in the absence of chelerythrine, the NSC and ClCa
amplitudes were 100 ± 8 pA and 33 ± 6 pA, respectively.
Also, the times-to-peak for these angiotensin-induced
conductances were not significantly (P ≥ 0.18) affected
by chelerythrine. Thus, these experiments support the
scenario that angiotensin II activates NSC and ClCa
channels by a PKC-independent mechanism.
In other experiments, we assessed the effect of
chelerythrine (1 µm) on the angiotensin-induced
contraction of pericytes. As with the induced NSC and
ClCa conductances, the percentage of pericytes contracting
in response to 500 nm angiotensin II was not significantly
(P = 0.36, Fisher’s exact test) affected by this PKC
inhibitor (Fig. 2B). We also observed that chelerythrine
did not significantly (P = 0.8) affect the magnitude of the
angiotensin-induced vasoconstriction (Fig. 2C). From
these experiments, we concluded that PKC activation is
not an essential step in mediating pericyte contraction and
vasoconstriction during exposure of retinal microvessels
to angiotensin II. However, it appears that PKC does
mediate the angiotensin-induced uncoupling of pericytes
from their microvascular neighbours.
Figure 7. Effect of angiotensin II on the membrane capacitive
current of pericytes located on a freshly isolated microvessels
A, left-hand panel, average of 10 traces (solid line) evoked by a
voltage step from −58 to −53 mV under control conditions. The
calculated first-order exponential fit is shown by the dotted line.
Right-hand panel, for the same cell, the average current trace (n = 10)
and the closely matched first-order exponential fit (dotted line) 2 min
after the onset of exposure to 500 nM angiotensin II. B, time course for
the effect of angiotensin on the capacitance transient. The area under
the current trace evoked by a 200 ms voltage step from −58 to
−38 mV was calculated at 2 s intervals before and during exposure of
pericytes (n = 4) to 500 nM angiotensin II; this area, expressed in
pA s−1, i.e, pCoulombs, is a measure of the charge displacement
during the capacitance transient.
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Discussion
This study shows that angiotensin II alters the physio-
logy of pericyte-containing retinal microvessels. Responses
to this peptide include the activation of NSC and ClCa
conductances whose depolarizing effect on pericytes
is sufficient to open VDCCs. In addition to changes
in ion channel activity, we found that angiotensin II
causes intracellular calcium levels to rise, pericytes to
contract and microvascular lumens to narrow. Our
experiments indicate that the influx of calcium through
NSC channels is a critical step linking the activation
of AT1 angiotensin receptors with pericyte contraction
and thereby vasoconstriction. Although not essential for
triggering contraction, calcium entry via the VDCCs
enhances the vasoconstrictive response of pericytes to
angiotensin II. Unexpectedly, we found that angiotensin II
not only regulates the contractility of pericytes, but
also functionally uncouples these cells from their micro-
vascular neighbours. Taken together, our observations
support the hypothesis that angiotensin II serves as
a vasoactive signal in the pericyte-containing retinal
microvasculature and suggest a previously unappreciated
complexity in the temporal and spatial dynamics of the
microvascular response to this peptide.
This is the first report of angiotensin II regulating
intercellular communication within blood vessels.
Recently, we demonstrated the other vasoactive signals,
i.e. endothelin-1 and ATP, also reversibly inhibit gap
junction pathways within the retinal microvasculature
(Kawamura et al. 2002, 2003). In our perforated-patch
clamp studies of hundreds of pericytes located on freshly
isolated retinal microvessels, a similar change in cell-to-cell
Figure 8. Effect of angiotensin II on pericyte currents during exposure of microvessels to chelerythrine
A, continuous current trace of a pericyte held at −103 mV and exposed to solution A supplemented with 1 µM
chelerythrine and, during the period indicated by the bar, 500 nM angiotensin II. Superimposed on the relatively
slowly changing NSC current are the transient ClCa currents. Prior to this recording, the microvessel was maintained
in the chelerythrine-containing solution for 30 min. B,C, peak amplitudes of the NSC and ClCa currents induced
by 500 nM angiotensin II in the absence and presence of 1 µM chelerythrine. For each group, seven pericytes were
sampled; currents were measured at −103 mV. Neither induced conductance was significantly (P > 0.36) affected
by chelerythrine.
communication has never occurred spontaneously. Thus,
we conclude that the inhibition of gap junction-mediated
communication is a newly discovered mechanism by
which certain signalling molecules regulate microvascular
function.
The experiments reported in this study support
the hypothesis that the closure of microvascular gap
junctions during exposure to angiotensin II is mediated
via a PKC-dependent mechanism. This is consistent
with our earlier work demonstrating that the PKC
activator, phorbol myristate, markedly reduces inter-
cellular communication in retinal microvessels (Oku
et al. 2001). However, because chelerythrine inhibits most
isoforms of PKC (Herbert et al. 1990), it remains to
be established which of the various PKC isoforms, i.e.
α, β2, δ and ζ (Moriarty et al. 2000; Suzuma et al.
2002), that are expressed by retinal pericytes and endo-
thelial cells play a role in the angiotensin-induced
inhibition of cell-to-cell communication. However, our
finding that a rise in pericyte calcium is required in
order for angiotensin II to uncouple pericytes suggests
a role for the calcium-dependent α, β2 and/or δ
isoforms. It is most likely that the activation by angiotensin
of a PKC isoform inhibits the function of microvascular
gap junctions by catalysing the phosphorylation of one
or more the connexins, i.e. 43, 37 and 40, expressed in
the pericyte-containing microvasculature of the retina (Li
et al. 2003; Fernandes et al. 2004). Consistent with this
idea, there is good evidence that the phosphorylation of
connexins in a variety of cell types results in a reduction
in the abundance of these molecules in the plasma
membrane (Lampe et al. 2000). However, we posit that the
rapid reversibility of the angiotensin-induced uncoupling
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of pericytes is probably explained by a transient functional
inhibition of connexins that remain within the membrane
of pericytes and endothelial cells. In agreement with this
possibility, the phosphorylation of certain connexins is
known to decrease their unitary conductance (Moreno
et al. 1994). Goals for the future are to identify the specific
type(s) of microvascular connexins and PKC isoforms
that are regulated by angiotensin II in the retinal micro-
vasculature.
Almost certainly the angiotensin-induced inhibition
of electrotonic transmission profoundly influences the
spatiotemporal characteristics of the microvascular
response to this peptide. It seems likely that exposure to
angiotensin II at a focal site along a microvessel would
evoke widespread depolarization as the voltage change
induced locally by the opening of NSC and ClCa channels
spreads electrotonically from cell to cell via gap junction
pathways, which are known to extensively interconnect
cells of the retinal microvasculature (Oku et al. 2001).
However, this intercellular transmission would cease when
angiotensin induces gap junction closure. As a result,
vasoconstriction would then be restricted to the site
directly exposed to this vasoactive peptide. Thus, this
model for the actions of angiotensin II in the retinal
microvasculature predicts that focally released
angiotensin II would initially affect blood flow throughout
a relatively large area of a microvascular network, but
subsequently the decrease in perfusion would be delimited
to the capillary segment directly exposed to this peptide.
Perhaps, by transiently regulating perfusion in upstream
vessels, angiotensin II quickly and effectively decreases
local capillary perfusion without causing sustained and
potentially harmful hypoperfusion in widespread areas
of the retina. Clearly, future experimental studies are
need to fully characterize the spatiotemporal features of
angiotensin’s effects on retinal microvessels.
A finding of this and other recent studies of retinal
microvessels (Kawamura et al. 2003; Wu et al. 2003)
is that pericytes appear to be functionally heterogenous
with regard to their contractility. For example, in this
study, maximal concentrations of angiotensin II evoked
a contractile response in only ∼40% of the pericytes. Even
though limitations in the sensitivity of our contraction
assay may underestimate the number of responding
pericytes, it seems clear that there are significant qualitative
differences in the contractile responses of these cells,
although we cannot exclude that our procedure to
isolate microvessels from the retina causes some
pericytes to become noncontractile. The failure of a
majority of the pericytes to contract does not appear to
be due to their lacking an induced increase in intracellular
calcium; angiotensin II caused the concentration of this
divalent cation to increase in nearly all (∼90%) monitored
pericytes. Perhaps, the threshold at which a rising
intracellular calcium concentration causes contraction
varies among the population of retinal pericytes. At
present, the functional significance of retinal microvessels
having a large population of pericytes that do not contract
in response to a vasoactive signal remains to be established.
However, since not all pericytes along a microvascular
segment need to contract in order to reduce blood flow,
the heterogeneity of pericyte contractility may provide
an adaptive advantage by being energy efficient. With
voltage changes being easily transmitted via gap junctions
from noncontractile pericytes to those that do contract
(Kawamura et al. 2003), retinal microvessels appear to be
designed to maximize detection of localized extracellular
signals while minimizing the energy needed to carryout
the vasoactive response.
Our identification of the mechanisms by which
angiotensin II regulates the contractility of retinal
pericytes raised the question as to whether similar events
take place in pericyte-containing microvessels located
in nonretinal tissues. At present, the descending vasa
recta of the kidney is the only other microvasculature in
which angiotensin’s effects on the membrane potential of
pericytes, the calcium level in these cells and the diameter
of vascular lumens are known (Pallone & Huang, 2002;
Rhinehart et al. 2002; Zhang et al. 2002). Similar to the
responses of retinal pericytes, exposure to angiotensin II
causes vasa recta pericytes to depolarize, calcium levels to
rise and microvascular lumens to narrow. An additional
similarity of retinal and vasa recta microvessels (Zhang
et al. 2002) is that VDCC inhibition diminishes, but
does not abolish, the vasoconstriction induced by
angiotensin II. This persistence of angiotensin-induced
contraction despite VDCC inhibition indicates that an
event, other than activation of these calcium channels,
mediates the angiotensin-induced contraction of
pericytes in both of these microvasculatures. In
retinal microvessels, our experiments revealed that
the opening of calcium-permeable NSC channels is
likely to be an essential event linking the activation of
angiotensin receptors with the triggering of pericyte
contraction and lumen narrowing. Whether angiotensin-
activated NSC channels also play a role in the response
of pericyte-containing microvessels in nonretinal
tissues remains to be determined. In fact, it may be
that angiotensin’s vasoactive effects on pericytes are
transduced by different mechanisms in different vascular
beds, as is the case for the effect of this peptide on vascular
smooth muscle (Nagahama et al. 2000). Consistent with
different pericyte-containing microvasculatures having
different transduction mechanisms, PKC inhibition
prevents angiotensin-induced vasoconstriction in the
pericyte-containing vasa recta (Zhang et al. 2004), but
not in the retinal microvasculature (Fig. 2C). Other
differences in the action of this peptide may exist, but
comparative data are limited. For example, it is not known
whether angiotensin II causes a functional uncoupling
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of vasa recta pericytes from other microvascular cells, as
it does in the retinal microvessels. Also, it is not known
whether reactive oxygen species mediate angiotensin’s
vasoconstrictive effect in microvessels of the retina, as
they do in the descending vasa recta (Zhang et al. 2004).
Nor do we know whether the pericyte contraction
triggered by the activtion of AT1 receptors is modulated
by the concomitant activation of AT2 receptors, as occurs
in vasa recta pericytes (Zhang et al. 2004). We speculate
that the mechanisms mediating angiotensin’s effects on a
tissue’s microvasculature have been selected to meet the
specialized functional demands of that tissue. A challenge
for the future is to determine the adaptive advantages of
the various pathways by which angiotensin II can regulate
the physiology of pericyte-containing microvessels.
Our conclusions concerning the mechanisms
by which angiotensin II induces vasoconstriction
in pericyte-containing microvessels are based on
experiments using freshly isolated retinal microvessels.
One benefit of studying microvessels in isolation is that
confounding effects mediated by nonvascular retinal cells
are eliminated. Also, it is possible to precisely control the
concentrations of agonists and inhibitors, as well as the
duration of exposure to these chemicals. Furthermore, in
contrast to cultured pericytes, use of isolated microvessels
permits electrophysiological, calcium-imaging and
time-lapse studies to be performed while these cells are
integral components of the microvasculature. This latter
advantage is of particular importance because pericytes
function as elements of multicellular functional units in
which intercellular communication is mediated via gap
junction pathways, which are regulated by vasoactive
signals (Kawamura et al. 2002; Kawamura et al. 2003)
and can be disrupted by pathophysiological conditions,
such as diabetes (Oku et al. 2001). However, even though
there are many experimental advantages to studying
freshly isolated microvessels, caution must be exercised.
For example, it remains to be demonstrated that the
effects of angiotensin II on ion channels, calcium levels,
pericyte contractility and cell-to-cell coupling occur
in vivo. Hence, an in vivo application of the imaging
and electrophysiological techniques used in this study
would be ideal, although at present this does not appear
to be feasible. Also, because intraluminal pressure is
likely to affect microvascular physiology, development of
methods to internally perfuse isolated microvessels will
be of importance. Yet, despite caveats, freshly isolated
microvessels provide an experimental preparation that
has allowed us to make new observations and propose
new hypotheses concerning the mechanisms by which
angiotensin II regulates the retinal microvasculature.
In summary, by activating several types of ion channels,
angiotensin II causes extracellular calcium to enter the
pericytes of retinal microvessels. As a result, these cells
contract, and microvascular lumens narrow. Adding
spatiotemporal complexity to these effects, angiotensin II
also inhibits intercellular communication. Thus, this
vasoactive signal not only regulates pericyte contractility,
but also affects the functional organization of the retinal
microvasculature.
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Time-lapse movie showing a freshly isolated rat retinal
microvessel before, during and after addition of 500 nM
angiotensin II to the perfusate
Differential interference contrast images were captured at 8 s
intervals for a period of 16 min. The frames labelled ‘angiotensin’
indicate when this pericyte-containing microvessel was exposed
to this vasoactive peptide. Two erythrocytes can be seen in
the microvascular lumen. During exposure to angiotensin II,
contraction of the pericyte located on the upper edge of the
microvessel caused the adjacent lumen to narrow.
This material can also be found at:
http://www.blackwellpublishing.com/products/journals/
suppmat/tjp/tjp593/tjp593sm.htm
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